ROHTO PHARMACEUTICAL CO.,LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,962 JPY | +1.37% |
|
+2.63% | +4.19% |
| Apr. 04 | Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen | MT |
| Apr. 04 | Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
ROHTO PHARMACEUTICAL CO., LTD. is a Japan-based company principally engaged in the health and beauty care area. The Company primarily provides eye care-related products, including eye drops and eye lotions; skin care-related products, including dermatological preparations, lip balms, sunscreens and functional cosmetics; oral medication and food-related products, including digestive medicines, Chinese herbal medicines and supplements, as well as extracorporeal test drugs and other products. The Company operates its business in domestic market and overseas markets, including Europe, Asia and America.
Sector
Pharmaceuticals
Calendar
2024-05-09
- Q4 2023 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2,922
JPY
Average target price
3,892
JPY
Spread / Average Target
+33.21%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.19% | 4.3B | |
| +25.61% | 660B | |
| +25.87% | 562B | |
| -5.24% | 358B | |
| +16.49% | 322B | |
| +8.28% | 297B | |
| +7.09% | 219B | |
| -9.12% | 196B | |
| +5.01% | 199B | |
| -8.75% | 149B |
- Stock Market
- Equities
- 4527 Stock
- News Rohto Pharmaceutical Co.,Ltd.
- Rohto Pharmaceutical : Fiscal H1 Profit Slips 15%
